Joel Renick
14Patents
9h-index
43Co-inventors
68Inventor score
Filing activity: May 22, 1998 → Nov 3, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7528143B2 | Bi-aryl meta-pyrimidine inhibitors of kinases | Chemistry; Metallurgy | 176 | Active |
| US7235576B1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | Chemistry; Metallurgy | 47 | Expired |
| US7351834B1 | ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | Chemistry; Metallurgy | 40 | Expired |
| US6344476B1 | Inhibition of p38 kinase activity by aryl ureas | Emerging Cross-Sectional Technologies | 35 | Expired |
| US7825246B2 | Bi-aryl meta-pyrimidine inhibitors of kinases | Chemistry; Metallurgy | 33 | Active |
| US8604042B2 | Bi-aryl meta-pyrimidine inhibitors of kinases | Chemistry; Metallurgy | 26 | Active |
| US7897623B2 | ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors | Emerging Cross-Sectional Technologies | 26 | Active |
| US7928239B2 | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas | Chemistry; Metallurgy | 11 | Expired |
| US8030487B2 | 2-amino—5-substituted pyrimidine inhibitors | Chemistry; Metallurgy | 9 | Active |
| US7456176B2 | Benzotriazine inhibitors of kinases | Chemistry; Metallurgy | 4 | Active |
| US9708334B2 | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10040759B2 | Substituted azetidinyl compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9012470B2 | Therapeutic 5,6,5-tricyclic analogs | Chemistry; Metallurgy | 0 | Active |
| US8481536B2 | Benzotriazine inhibitors of kinases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.